Welcome to our dedicated page for Maximus news (Ticker: MMS), a resource for investors and traders seeking the latest updates and insights on Maximus stock.
Maximus, Inc. reports developments tied to its role as a provider of tech-enabled government services for public programs. The company supports government agencies with business process management, technology solutions, health insurance eligibility and enrollment programs, clinical services, assessments, appeals and independent medical reviews across U.S. Federal Services, U.S. Services and international operations.
Recurring news includes fiscal results, guidance updates, sales-pipeline commentary, segment trends, clinical program demand and productivity initiatives. Company updates also cover AI-enabled tools such as Accuracy Assistant for state SNAP programs, quarterly cash dividends, common-stock repurchase authorizations and governance changes involving senior legal and corporate-secretary roles.
Maximus (NYSE: MMS) announced a quarterly cash dividend of $0.33 per share, a 10% increase from the prior quarterly dividend of $0.30.
The Board approved the dividend payable on March 2, 2026 to shareholders of record on February 13, 2026. Management said the increase reflects recent earnings growth and the company’s disciplined capital deployment strategy.
Maximus (NYSE: MMS) reported fiscal 2025 results with $5.43B revenue, up 2.4% year-over-year and 3.9% organic growth driven by U.S. Federal clinical programs. Fiscal operating margin expanded to 9.7% and adjusted EBITDA margin to 12.9%. Adjusted diluted EPS was $7.36 and free cash flow totaled $366M. The company repurchased ~5.8M shares for $456.6M and ended the year with net leverage of 1.5x. Management declared a quarterly dividend of $0.30 per share payable Dec 1, 2025. For fiscal 2026, Maximus provided guidance: revenue of $5.225B–$5.425B, adjusted EBITDA margin ~13.7%, adjusted diluted EPS $7.95–$8.25, and free cash flow $450M–$500M.
Maximus (NYSE: MMS) was awarded a Joint Cyber Command & Control Readiness (JCC2-R) contract by the U.S. Air Force Life Cycle Management Center with a potential value of $86 million to support engineering analysis, software modification, maintenance, enhancements, and maturation of existing architecture and infrastructure.
The award is a second task order from the Air Force and carries a period of performance of a base year plus four one-year option periods and an optional six-month extension, expanding Maximus' technology footprint in the defense sector.
Maximus (NYSE: MMS) was awarded a new $31 million contract by the Massachusetts Health Connector to provide enrollment and premium billing services under a four-year base term.
The scope includes credit/debit processing, enrollment data reconciliation with carriers, federal reporting notices, and a redesigned digital member portal to serve > 370,000 marketplace members. Maximus said its technology will interface with Health Connector systems, insurers, and vendors to modernize premium payments and member experience.
Maximus (NYSE: MMS) will release fiscal 2025 fourth quarter and year-end results for the periods ended September 30, 2025 at 6:30 a.m. ET on Thursday, November 20, 2025. The company will host a public conference call and webcast the same day at 9:00 a.m. ET.
Investors can join by phone at 877.407.8289 (Domestic) or +1.201.689.8341 (International), or stream the webcast. A recording will be posted at investor.maximus.com for later access.
Maximus (NYSE: MMS) announced on October 6, 2025 that its Board approved a quarterly cash dividend of $0.30 per share. According to the press release, the dividend is payable on December 1, 2025 to shareholders of record on November 14, 2025. The PR states these dates and the dividend amount only.
Maximus (NYSE: MMS) has secured a five-year, $62 million contract from Pennsylvania's Department of Human Services to continue managing the Pennsylvania Enrollment Assistance Program. The renewed contract expands services to include Children's Health Insurance Program (CHIP) recipients and introduces significant digital enhancements.
The company will implement new technology solutions including 24/7 web chat, text messages, and email notifications. Maximus will also deploy an AI-based training tool for customer service agents and lead statewide outreach efforts. The company has been providing healthcare information and enrollment services to Pennsylvanians since 2009.
Maximus (NYSE:MMS) announced a significant expansion of its stock repurchase program, increasing the total authorization to $400 million. This expansion includes approximately $32.7 million remaining from the previous program. The company will conduct purchases opportunistically through open market transactions, 10b5-1 plans, or private negotiations.
Since June 30, 2025, Maximus has already purchased 375,898 shares for approximately $31.6 million. The program has no specified expiration date and can be modified or suspended at the company's discretion. CEO Bruce Caswell emphasized that this decision reflects the company's strong momentum and its strategic role in government service delivery.
Maximus (NYSE: MMS) has achieved Cybersecurity Maturity Model Certification (CMMC) Level 2, demonstrating its enhanced capability to secure national defense data and meet Department of Defense (DoD) cybersecurity requirements. The certification was obtained through a Certified Third-Party Assessor Organization (C3PAO).
The CMMC 2.0 program assesses defense contractors' cybersecurity posture and aligns with National Institute of Standards and Technology standards. This certification enables faster deployment for government programs by avoiding lengthy Authorization to Operate (ATO) delays, reducing startup risks, and positioning Maximus competitively in federal contracting.
Maximus (NYSE: MMS) reported strong Q3 FY2025 results, with revenue increasing 2.5% to $1.35 billion and organic growth of 4.3%. The company raised its full-year guidance for the third consecutive time, now expecting revenue between $5.375-$5.475 billion. Diluted EPS reached $1.86, with adjusted EPS at $2.16.
The U.S. Federal Services Segment led growth with an 11.4% increase to $761.2 million, while U.S. Services Segment declined 6.9% to $439.8 million. The company declared a quarterly dividend of $0.30 per share, payable August 31, 2025. Year-to-date signed contract awards totaled $3.37 billion, with a robust sales pipeline of $44.7 billion.